Using Ribonucleoprotein-based CRISPR/Cas9 to Edit Single Nucleotide on Human Induced Pluripotent Stem Cells to Model Type 3 Long QT Syndrome (SCN5A±).
Stem Cell Rev Rep
; 19(8): 2774-2789, 2023 11.
Article
in En
| MEDLINE
| ID: mdl-37653182
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Long QT Syndrome
/
Induced Pluripotent Stem Cells
Type of study:
Guideline
/
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Stem Cell Rev Rep
Year:
2023
Type:
Article
Affiliation country:
Ireland